Parisi, A., Parisi, A., Giampieri, R., Mammarella, A., Felicetti, C., Salvatore, L., . . . Ghidini, M. (2022, August). Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis. Frontiers in Oncology.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Parisi, Alessandro, et al. "Primary Versus Secondary Antiemetic Prophylaxis with NK1 Receptor Antagonists in Patients Affected by Gastrointestinal Malignancies and Treated with a Doublet or Triplet Combination Regimen Including Oxaliplatin And/or Irinotecan Plus Fluoropyrimidines: A Propensity Score Matched Analysis." Frontiers in Oncology Aug. 2022.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Parisi, Alessandro, et al. "Primary Versus Secondary Antiemetic Prophylaxis with NK1 Receptor Antagonists in Patients Affected by Gastrointestinal Malignancies and Treated with a Doublet or Triplet Combination Regimen Including Oxaliplatin And/or Irinotecan Plus Fluoropyrimidines: A Propensity Score Matched Analysis." Frontiers in Oncology, Aug. 2022.